Clinical Trials
4 trialsNCT04785768 2025-05-22
IV PCA With or Without Continuous Dose vs Oral Opioid to Maintain Analgesia for Severe Cancer Pain After Successful Titration
Fujian Cancer Hospital
Phase 3 Completed
NCT03375515 2021-03-08
PCA vs Non-PCA Intravenous Hydromorphone Titration for Severe Cancer Pain
Fujian Cancer Hospital
Phase 3 Completed
NCT01946555 2016-04-14
RER
Mario Negri Institute for Pharmacological Research
Completed
NCT00766831 2013-10-23
An Efficacy and Safety Study of Hydromorphone Oral Osmotic System (OROS) in Korean Participants With Cancer Pain
Janssen Korea, Ltd., Korea
Phase 4 Completed